NASDAQ:FOLD

Amicus Therapeutics Stock Predictions

etoro logo Buy FOLD
*Your capital is at risk
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

FOLD Prediction Chart

FOLD Predictions History

Latest community submissions for FOLD.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 22, 2025 $13.94 -1.68% $14.21 X 98.12% 0
Dec 22, 2025 $14.03 -1.05% $14.21 X 98.74% 1
Dec 22, 2025 Bullish $14.21 V 1
Oct 28, 2025 $8.75 -1.47% $8.86 V 98.75% 2
Oct 28, 2025 $8.80 -0.92% $8.86 V 99.31% 4
Oct 28, 2025 Bullish $8.86 V 0
Sep 10, 2025 $20.00 +153.49% Unrealistic Excluded from avg $7.94 V 0.00% 1
Sep 5, 2025 $20.00 +149.38% Unrealistic Excluded from avg $7.99 X 0.00% 0
Aug 29, 2025 $17.00 +122.22% Unrealistic Excluded from avg $7.59 X 0.00% 0
Jun 30, 2025 $5.87 -0.95% $5.73 V 97.49% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for FOLD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AMICUS THERAPEUTICS
Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE